Prognostic value of the New York Heart Association classification in end-stage renal disease

Nephrology Dialysis Transplantation

Volumn 22, Issue 5, 2007, Pages 1377-1382

  Postorino, Maurizio ^a   Marino, Carmen ^a   Tripepi, Giovanni ^a   Zoccali, Carmine ^a  

^a CNR Consiglio Nazionale delle Ricerche   (Italy)

Author keywords

Dialysis; Heart failure; Khan index; NYHA classification; Renal disease severity score

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; DIALYSIS; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; MORTALITY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RECEIVER OPERATING CHARACTERISTIC; REGISTER; RISK ASSESSMENT; STATISTICAL MODEL; VALIDITY;

AGED; COHORT STUDIES; FEMALE; HUMANS; ITALY; KAPLAN-MEIERS ESTIMATE; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REGISTRIES; SEVERITY OF ILLNESS INDEX;

EID: 34447550511     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfl813     Document Type: Article

References (24)

1. Foley RN. Clinical epidemiology of cardiac disease in dialysis patients: left ventricular hypertrophy, ischemic heart disease, and cardiac failure. Semin Dial 2003; 16: 111-117
2. Zoccali C. Traditional and emerging cardiovascular and renal risk factors: An epidemiollogic perspective. Kidney Int 2006; 70: 26-33
3. National Kidney Foundation: K/DOQI Clinical Practice Guidelines for Cardiovascular Disease in Dialysis Patients. Am J Kidney Dis 2005; 45: S1-S45.
4. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE. Hypoalbuminemia, cardiac morbidity, and mortality in end-stage renal disease. J Am Soc Nephrol 1996; 7: 728-736
5. Foley RN, Parfrey PS, Harnett JD et al. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int 1995; 47: 186-192
6. Stack AG, Bloembergen WE. A cross-sectional study of the prevalence and clinical correlates of congestive heart failure among incident US dialysis patients. Am J Kidney Dis 2001; 38: 992-1000
7. Hunt SA. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol 2005; 46: E1-e82
8. Remme WJ, Swedberg K. Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J 2001; 22: 1527-1560
9. Postorino M, Zoccali C. NYHA classification in dialysis patients [Abstract]. Nephrol Dial Transplant 2002; 17: 12
10. Khan IH, Catto GR, Edward N, Fleming LW, Henderson IS, MacLeod AM. Influence of coexisting disease on survival on renal-replacement therapy. Lancet 1993; 341: 415-418
11. Craven J, Littlefield C, Rodin G, Murray M. The Endstage Renal Disease Severity Index (ESRD-SI). Psychol Med 1991; 21: 237-243
12. Altman DG. Weighted kappa. Practical statistics for medical research Chapman & Hall, London, UK: 1991; 406-407
13. Postorino M, Marino C, Alati G et al. A renal disease severity index: Application in a regional registry of dialysis and transplantation [Abstract]. Nephrol Dial Transplant 1995; 10: 1021
14. Collet D. Modelling survival data in medical research. Chapman & Hall, London, UK: 1994; 72-85
15. Hosmer DW, Lemeshow S. Assessment of model adequacy. Applied survival analysis. Wiley & Sons, New York, USA: 1999; 196-240
16. Altman DG. Two further ways for looking at diagnostic tests: The likelihood ratio and the ROC curve. In: Altman DG, ed. Practical statistics for medical research. Chapman & Hall, London, UK: 1991; 416-418
17. McKee PA, Castelli WP, McNamara PM, Kannel WB. The natural history of congestive heart failure: The Framingham study. N Engl J Med 1971; 285: 1441-1446
18. Chen J, Muntner P, Hamm LL et al. The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med 2004; 140: 167-174
19. Kurella M, Lo JC, Chertow GM. Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. J Am Soc Nephrol 2005; 16: 2134-2140
20. Parfrey PS, Foley RN, Harnett JD, Kent GM, Murray DC, Barre PE. Outcome and risk factors for left ventricular disorders in chronic uraemia. Nephrol Dial Transplant 1996; 11: 1277-1285
21. Zoccali C, Benedetto FA, Mallamaci F et al. Prognostic impact of the indexation of left ventricular mass in patients undergoing dialysis. J Am Soc Nephrol 2001; 12: 2768-2774
22. O'Brien BJ, Buxton MJ, Patterson DL. Relationship between functional status and health-related quality-of-life after myocardial infarction. Med Care 1993; 31: 950-955
23. Registro Calabrese di Dialisi e Trapianto. Performance of a renal disease severity score in predicting hospitalization and mortality in dialysis patients [Abstract]. Nephrol Dial Transplant 1996; 11: A206
24. Hemmelgarn BR, Manns BJ, Quan H, Ghali WA. Adapting the Charlson comorbidity index for use in patients with ESRD. Am J Kidney Dis 2003; 42: 125-132